Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 000616.SZ
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
17%
Leverage & Liquidity Bad
0%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -35.63 0.12 0.19
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -19365.49 -85.27 -0.44
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 1.03 2.82 2.79
Cash -66.27 < 0.005 < 0.005
Capex -100.00 < 0.005 0.00
Free Cash Flow 99.65 < 0.005 -0.86
Revenue -70.72 < 0.005 0.02
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 89.57 0.33 -0.17
Operating Margin 93.45 -1.18 -17.98
ROA 99.65 < 0.005 -0.23
ROE 99.65 < 0.005 -0.31
ROIC 99.37 < 0.005 -0.15
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 000616.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 000616.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 000616.SZ is permitted for members.